Literature DB >> 11037654

[Bellini's carcinoma. Our experience].

E De Diego Rodríguez1, C Pascual Soria, J L Gutiérrez Baños, B Martín García, R Hernández Rodríguez, J A Portillo Martín, M A Correas Gómez, J I Del Vale Schaan, A Roca Edreira, A Villanueva Peña, M A Rado Velázquez, A Hernández Castrillo.   

Abstract

OBJECTIVE: To present our experience with Bellini duct carcinoma, a rare form of renal adenocarcinoma with well-defined histological, cytogenetic and immunohistochemical characteristics. The literature is reviewed. METHODS/
RESULTS: We reviewed the records of 430 patients with renal tumor that had been treated over a 10-year period. Only 6 cases with Bellini duct carcinoma were found. The mean age was 60 years, all patients were male and hematuria and lumbar pain were the most common clinical manifestations. Diagnosis was made by imaging techniques (US, urography, CT). The definitive diagnosis was based on the histological and immunohistochemical findings following nephrectomy. The one-year and three-year survival rates were 50% and 0%, respectively, indicating the aggressive nature of this variant of renal adenocarcinoma.
CONCLUSIONS: Bellini duct carcinoma is an uncommon variant of renal carcinoma with nonspecific clinical features. It is a very aggressive tumor type whose treatment is only by nephrectomy and the outcome is poor.

Entities:  

Mesh:

Year:  2000        PMID: 11037654

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  2 in total

Review 1.  Bellini duct carcinoma: review of diagnosis and management.

Authors:  Iqbal Singh; G Nabi
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Extrarenal multiorgan metastases of collecting duct carcinoma of the kidney: a case series.

Authors:  Hisao Nakamura; Yasuyuki Kuirhara; Kazuhiko Matsushita; Akehide Sakai; Toshio Yamaguchi; Yasuo Nakajima
Journal:  J Med Case Rep       Date:  2008-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.